Evaluation of in vitro cytotoxicity and ex-vivo genotoxicity in compounds from Pavonia glazioviana Gürke brazilian species of the Malvaceae sensu lato family
DOI:
https://doi.org/10.9771/cmbio.v21i1.47445Keywords:
phytotherapy; hemolytic; antihemolytic; genotoxicAbstract
Introduction: Alternative therapies using medicinal plants and herbal medicines are quite common in Brazil. Among several Brazilian plant species used in therapies, the species of the Malvaceae family stand out. Objetctives: The present study aimed to evaluate the in vitro cytotoxicity and ex-vivo genotoxicity in compounds of the Brazilian Pavonia glazioviana Gürke belonging to the Malvaceae family. Methodology: In vitro methods were used to verify the cytotoxic potential through hemolytic and antihemolytic assays and the ex-vivo genotoxic analysis. The Crude Etanolic Extract (CEE) and Cloroformic Fraction (CF) was obtained in vegetal sample used on this study. Results: The CEE-Pg and CF-Pg products only showed a low cytotoxic effect at the concentrations of 50 and 100 µg/mL. The exposure to the concentrations of 500 and 1000 µg/mL showed a high to moderate hemolytic index with lysis higher than 60%. A moderate anti-hemolytic effect was described in all samples treated with 500 and 1000 µg/mL, with hemolysis <60%. In addition, the compounds showed low ex-vivo genotoxic effect with a general index of normal cells greater than 84% at all concentrations. Conclusion: The results suggest a low toxic profile of the compounds obtained from the Pavonia glazioviana Gürke species belonging to the Malvaceae family, indicating safe limits for the use of these natural products.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Journal of Medical and Biological Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Medical and Biological Sciences reserves all copyrights of published works, including translations, allowing, however, their subsequent reproduction as transcription, with proper citation of source, through the Creative Commons license. The periodical has free and free access.